SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 74 filers reported holding SERES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,000 | -8.6% | 13,602 | +83.5% | 0.00% | – |
| Q2 2023 | $35,000 | +52.2% | 7,411 | +78.8% | 0.00% | – |
| Q1 2023 | $23,000 | -65.2% | 4,144 | -64.9% | 0.00% | – |
| Q4 2022 | $66,000 | +500.0% | 11,809 | +630.3% | 0.00% | – |
| Q3 2022 | $11,000 | -83.1% | 1,617 | -91.5% | 0.00% | – |
| Q2 2022 | $65,000 | -59.9% | 18,977 | -17.2% | 0.00% | – |
| Q1 2022 | $162,000 | -42.1% | 22,916 | -31.9% | 0.00% | – |
| Q4 2021 | $280,000 | +582.9% | 33,636 | +466.2% | 0.00% | – |
| Q3 2021 | $41,000 | -64.0% | 5,941 | +24.7% | 0.00% | – |
| Q2 2021 | $114,000 | +119.2% | 4,765 | +90.3% | 0.00% | – |
| Q1 2021 | $52,000 | -68.5% | 2,504 | -62.8% | 0.00% | – |
| Q4 2020 | $165,000 | -55.4% | 6,739 | -48.3% | 0.00% | – |
| Q3 2020 | $370,000 | +496.8% | 13,042 | +0.8% | 0.00% | – |
| Q2 2020 | $62,000 | +67.6% | 12,940 | +23.9% | 0.00% | – |
| Q1 2020 | $37,000 | +236.4% | 10,445 | +227.2% | 0.00% | – |
| Q4 2019 | $11,000 | +450.0% | 3,192 | +432.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 600 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -62.5% | 600 | -45.6% | 0.00% | – |
| Q3 2018 | $8,000 | +14.3% | 1,103 | +32.7% | 0.00% | – |
| Q2 2018 | $7,000 | +40.0% | 831 | +17.5% | 0.00% | – |
| Q1 2018 | $5,000 | -37.5% | 707 | -12.5% | 0.00% | – |
| Q4 2017 | $8,000 | -81.4% | 808 | -70.3% | 0.00% | – |
| Q3 2017 | $43,000 | +330.0% | 2,716 | +193.0% | 0.00% | – |
| Q2 2017 | $10,000 | -28.6% | 927 | -27.3% | 0.00% | – |
| Q1 2017 | $14,000 | +100.0% | 1,275 | +92.6% | 0.00% | – |
| Q4 2016 | $7,000 | +75.0% | 662 | +120.7% | 0.00% | – |
| Q3 2016 | $4,000 | +300.0% | 300 | +1664.7% | 0.00% | – |
| Q4 2015 | $1,000 | -88.9% | 17 | -94.3% | 0.00% | – |
| Q3 2015 | $9,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |